Skip to Main Content

Paper Details

Population-Level Implications of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Preserved Ejection Fraction in the US.
JAMA Cardiol
10
2023
Chronic Heart Failure, DAPA, Dapagliflozin, Empagliflozin, Glucose, HF, Heart Failure, Patients, SGLT-2, Sodium-, Sodium-Glucose Cotransporter-2, cardiovascular, glucose, heart failure, patients, sodium-, sodium-glucose cotransporter-2
Author NameAffiliation
Gregg C FonarowAhmanson-university of california los angeles Cardiomyopathy Center, University of California Los Angeles
Gregg C Fonarow
Gregg C FonarowAhmanson-university of california los angeles Cardiomyopathy Center, University of California Los Angeles
Gregg C Fonarow
  • 1 - 4

Datasets

Release 1.2